S. 4109: Stem Cell Therapeutic and Research Reauthorization Act of 2026

S. 4109 is a federal bill in the 119th Congress. The Stem Cell Therapeutic and Research Reauthorization Act of 2026 reauthorizes and revises federal programs administered by the Health Resources and Services Administration that facilitate bone marrow and umbilical cord blood transplants from unrelated… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.